$AMRS Amyris’s Pathways Program offers bio-based molecule development through a low-cost, low-risk program
Program Features
Early access to Amyris’s next-generation synthetic biology technology Low initial payment with a milestone approach that allows sponsors more informed decision making to proceed with sponsoring further development Exclusive rights granted to sponsor within the negotiated field if the molecule successfully completes development
How it works
Amyris begins building a bio-synthetic production solution after a molecule is sponsored via low initial payment. The tiered milestone stages help guide sponsors as the program advances. After each phase, the sponsor can decide to sponsor the next phase or exit the program. Making great technology even better Amyris’s technology investment agreement with the Defense Advanced Research Projects Agency (DARPA) is resulting in a rapid technological advancement of our already industry-leading biosynthetic platform. The Pathways Program offers sponsors access to this technology transformation.
News 
Market Data 
Discover 
